Elicio Therapeutics' TLR9 agonist AMP-CpG induces potent immune and antitumoral effects March 29, 2022
NSF grant supports Iaso's vaccine delivery research targeting infectious diseases and cancer March 15, 2022
AEterna Zentaris expands research agreement with JMU to support COVID-19 and Chlamydia vaccines March 11, 2022
RSS